265 related articles for article (PubMed ID: 24839054)
21. Left ventricular hypertrophy among predialysis chronic kidney disease patients: Sindh institute of urology and transplantation experience.
Ali T; Idrees MK; ; Akhtar SF
Saudi J Kidney Dis Transpl; 2017; 28(6):1375-1380. PubMed ID: 29265050
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease.
Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
Clin Exp Nephrol; 2013 Oct; 17(5):730-742. PubMed ID: 23318981
[TBL] [Abstract][Full Text] [Related]
23. Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care.
Ravera M; Noberasco G; Signori A; Re M; Filippi A; Cannavò R; Weiss U; Cricelli C; Deferrari G; Paoletti E
Am J Hypertens; 2013 May; 26(5):700-7. PubMed ID: 23391620
[TBL] [Abstract][Full Text] [Related]
24. Insulin resistance is a risk factor for the progression of chronic kidney disease.
Kobayashi H; Tokudome G; Hara Y; Sugano N; Endo S; Suetsugu Y; Kuriyama S; Hosoya T
Clin Nephrol; 2009 Jun; 71(6):643-51. PubMed ID: 19473633
[TBL] [Abstract][Full Text] [Related]
25. Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison.
Nardi E; Mulè G; Giammanco A; Mattina A; Geraci G; Nardi C; Averna M
Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):137-144. PubMed ID: 33092976
[TBL] [Abstract][Full Text] [Related]
26. [Blood pressures values during evaluation of 24-h ambulatory blood pressure monitoring and left ventricular hypertrophy in patients with chronic renal failure treated with hemodialysis (HD)].
Wanic-Kossowska M; Leman P; Kobelski M; Czekalski S
Pol Arch Med Wewn; 2002 Jan; 107(1):29-35. PubMed ID: 12046341
[TBL] [Abstract][Full Text] [Related]
27. Metabolic syndrome as risk factor for left ventricular hypertrophy in children with chronic kidney disease.
Drożdż M; Moczulska A; Rudziński A; Drożdż D
Front Endocrinol (Lausanne); 2023; 14():1215527. PubMed ID: 37324258
[TBL] [Abstract][Full Text] [Related]
28. The relationship between left ventricular mass and insulin resistance in obese patients.
Bulut C; Helvaci A; Adas M; Ozsoy N; Bayyigit A
Indian Heart J; 2016; 68(4):507-12. PubMed ID: 27543473
[TBL] [Abstract][Full Text] [Related]
29. Impact of achieved systolic blood pressure on renal function in hypertensive patients.
Okin PM; Kjeldsen SE; Devereux RB
Eur Heart J Qual Care Clin Outcomes; 2016 Oct; 2(4):271-276. PubMed ID: 29474712
[TBL] [Abstract][Full Text] [Related]
30. Left ventricular hypertrophy among chronic kidney disease patients in Ghana.
Amoako YA; Laryea DO; Bedu-Addo G; Nkum BC; Plange-Rhule J
Pan Afr Med J; 2017; 28():79. PubMed ID: 29255549
[TBL] [Abstract][Full Text] [Related]
31. Lipid profile and left ventricular geometry pattern in obese children.
Bjelakovic B; Stefanutti C; Vukovic V; Kavaric N; Saranac L; Klisic A; Lukic S; Stankovic S; Jovic M; Prijic S; Bjelakovic M; Banach M
Lipids Health Dis; 2020 May; 19(1):109. PubMed ID: 32456629
[TBL] [Abstract][Full Text] [Related]
32. Correlation of anemia, secondary hyperparathyroidism with left ventricular hypertrophy in Chronic Kidney Disease patients.
Datta S; Abraham G; Mathew M; Somasundaram H; Muralidharan TR; Moorthy A; Sathyasekaran ; Leslie N
J Assoc Physicians India; 2006 Sep; 54():699-703. PubMed ID: 17212016
[TBL] [Abstract][Full Text] [Related]
33. [Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease].
Vasilyeva MP; Rudenko TE; Kutyrina IM; Solomakhina NI
Ter Arkh; 2015; 87(6):17-22. PubMed ID: 26281190
[TBL] [Abstract][Full Text] [Related]
34. Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease.
Chang JM; Chen SC; Huang JC; Su HM; Chen HC
Am J Med Sci; 2014 Mar; 347(3):183-9. PubMed ID: 23426086
[TBL] [Abstract][Full Text] [Related]
35. [B-type natriuretic peptide as a marker of cardiac dysfunction in children with chronic kidney disease].
Drożdż T; Kwinta P; Kordon Z; Sztefko K; Rudziński A; Zachwieja K; Miklaszewska M; Czarnecka D; Drożdż D
Pol Merkur Lekarski; 2018 Apr; 44(262):171-176. PubMed ID: 29775443
[TBL] [Abstract][Full Text] [Related]
36. Renal insufficiency in non-diabetic subjects: relationship of MTHFR C677t gene polymorphism and left ventricular hypertrophy.
Trovato GM; Catalano D; Ragusa A; Martines GF; Tonzuso A; Pirri C; Buccheri MA; Di Nora C; Trovato FM
Ren Fail; 2013; 35(5):615-23. PubMed ID: 23534584
[TBL] [Abstract][Full Text] [Related]
37. Left ventricular hypertrophy in a contemporary cohort of autosomal dominant polycystic kidney disease patients.
Chen H; Watnick T; Hong SN; Daly B; Li Y; Seliger SL
BMC Nephrol; 2019 Oct; 20(1):386. PubMed ID: 31653199
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of combined target-organ damage in patients with essential hypertension.
Carpinella G; Pagano G; Buono F; Petitto M; Guarino G; Orefice G; Rengo G; Trimarco B; Morisco C
Am J Hypertens; 2015 Jan; 28(1):127-34. PubMed ID: 24936579
[TBL] [Abstract][Full Text] [Related]
39. [Left ventricular hypertrophy among hypertensive patients with diminished glomerular filtration rate].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Oct; 25(148):309-14. PubMed ID: 19145927
[TBL] [Abstract][Full Text] [Related]
40. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients.
Wang AY; Wang M; Woo J; Law MC; Chow KM; Li PK; Lui SF; Sanderson JE
Kidney Int; 2002 Aug; 62(2):639-47. PubMed ID: 12110029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
